Medical Cannabis
France’s Final Medical Cannabis Decree Could Be Complete in the ‘Coming Weeks’
Frances’ incoming medical cannabis framework is expected to take the final step before it can be signed into law in the ‘coming weeks’.
france
40stories
16 Octlast updated
More in france
- Medical Cannabis
France Breaks Medical Cannabis Deadlock as Reimbursement Decree Filed for Legal Review
France’s incoming generalised medical cannabis framework has edged tantalisingly close to clearing its last remaining hurdle, as the outstanding decree governing the reimbursement of cannabis medicines has been submitted to France’s highest administrative court.
- Medical Cannabis
France Sets July Deadline for Medical Cannabis Regulations as Withheld Study Shows Opioid Reductions
France’s health minister has confirmed to Agence France-Presse (AFP) that the delayed regulatory texts needed to push through its incoming generalised medical cannabis market will be published next month (July 2026).
- Data & Analysis
European Cannabis Insights Summit 2026: Patients & Politics Post-Reclassification
Since April 2024, Berlin has cemented its place as the spiritual centre of the European cannabis industry.
- CBD Market
Latest French CBD Crackdown To Be Challenged In Court
French trade groups are seeking to overturn the ban on the sale of CBD food supplements in an attempted re-run of the successful 2022 removal of the ban on the sale of flowers.
- Cultivation
PGP Farmer Launches 30-Variety Dutch Trial to Set Dordogne Production Blueprint
PGP Farmer, the French biotech developing what it describes as the country’s first EU-GMP medical cannabis production site, has launched a proof-of-concept phenotyping programme in the Netherlands, testing 30 cannabis genotypes from its own genetic library to determine which varieties will be cultivated at its Dordogne facility.
- CBD Market
The War on Europe’s Legal Hemp Industry
In April 2025, the Italian government used emergency constitutional powers to bypass parliament and reclassify non-intoxicating hemp as a narcotic, regardless of THC content, following multiple failed attempts to decimate the industry.
- International Regulation
France’s Medical Cannabis Framework: Built for Patients or for Regulators?
The French medical cannabis market is now in the very final stage of decision-making before being implemented nationally, as the HAS presented its draft for the pricing and reimbursement strategy earlier this week.
- Medical Cannabis
France’s Long-Awaited Medical Cannabis Reimbursement Framework to Be Revealed Next Week
French authorities will present a first draft of the long-awaited pricing and reimbursement decree for medical cannabis on February 18, marking a critical milestone in the country’s drawn-out transition from pilot programme to permanent framework.
